Early ambulation protocol after diagnostic transfemoral cerebral angiography: an evidence-based practice project

BMC Neurology

Table 2 Comparison of Complications after transfemoral angiography in two groups

Variable	Subgroup	Groups		P value
Variable	Subgroup	Experimental N = 107	Control N = 107	P value
Bleeding event, n (%)	no	106 (99.07)	104 (97.20)	0.621^a
Bleeding event, n (%)	yes	1 (0.93)	3 (2.80)	0.621^a
Time of bleeding(after surgery), h		0.00 (0.00, 0.00)	0.00 (0.00, 0.00)	0.318^b
Amount of bleeding, ml		0.00 (0.00, 0.00)	0.00 (0.00, 0.00)	0.321^b
Hematoma event, n (%)	no	107	105	0.498 ^a
	yes	0	2	0.498 ^a
Hematoma size, cm²		0.00 (0.00, 0.00)	0.00 (0.00, 0.00)	0.156^b
Ecchymosis size, cm²		0.00 (0.00, 0.00)	0.00 (0.00, 0.00)	0.031^b
Urinary retention, n (%)	no	104 (97.20)	98 (91.59)	0.075^c
Urinary retention, n (%)	yes	3 (2.80)	9 (8.41)	0.075^c
urinary catheter, n (%)	no	106 (99.07)	101 (94.39)	0.119^a
urinary catheter, n (%)	yes	1 (0.93)	6 (5.61)	0.119^a
Time of urinary catheter(after surgery), h		0.00 (0.00, 0.00)	0.00 (0.00, 0.00)	0.054^b
Other vascular complications, n (%)	no	107 (100)	107 (100)	NA
Other vascular complications, n (%)	yes	0 (0)	0 (0)	NA

Other vascular complications include: arteriovenous fistula, pseudoaneurysm, retroperitoneal hematoma, and lower-extremity deep vein thrombosis (DVT)
Abbreviation: NA Not applicable
^aFisher’s exact test
^bMann-Whitney test
^cPearson’s chi-squared test

ISSN: 1471-2377